Jeffrey A M Coull

Title: The Innovative Contributions of Jeffrey A M Coull

Introduction

Jeffrey A M Coull is a notable inventor based in Toronto, Canada, recognized for his significant contributions to the field of pain management through innovative methods and products. With a total of four patents to his name, Coull has focused on the modulation of neuroglia-derived BDNF and CNS intracellular chloride levels to address pain and nociception.

Latest Patents

Coull's latest patents include groundbreaking work on the modulation of neuroglia-derived BDNF in the treatment and prevention of pain. This patent describes methods and products aimed at attenuating or treating pain by modulating neuroglia-derived BDNF expression or activity. Additionally, it outlines commercial packages and uses based on this modulation. Another significant patent focuses on identifying compounds for the treatment of pain, detailing methods that involve the modulation of CNS intracellular chloride levels. This patent also discusses the potential modulation of chloride transporters, such as the KCC2 potassium-chloride cotransporter, and includes related methods for diagnosing and prognosticating pain.

Career Highlights

Throughout his career, Coull has worked with esteemed institutions, including Université Laval. His research has contributed to advancements in understanding pain mechanisms and developing effective treatments.

Collaborations

Coull has collaborated with notable individuals in his field, including Yves De Koninck and Paul De Koninck, enhancing the impact of his research through shared expertise.

Conclusion

Jeffrey A M Coull's innovative work in pain management exemplifies the importance of research and development in addressing complex medical challenges. His contributions continue to influence the field and offer hope for improved treatment options.